Phonological problems: Why the name of a COVID-19 vaccine matters
The issue of nomenclature and confusion due to sound-alike and name-alike vaccines doesn’t find any mention in Covid-19 vaccination strategy;…
The warning lights are on for malaria medicines in Africa
Sulfadoxine-pyrimethamine, an alternative drug, was also showing signs of failure
COVID-19: It’s time to look at the finer details of South Africa’s pandemic picture
The current resurgence driven by the Delta variant finally appears to be subsiding in all nine provinces
Lateral thoughts: COVID-19 vaccines and a game of chance
Would you be compensated for adverse reactions to the COVID-19 vaccines?
Global COVID-19 death toll crosses 4 million
The total COVID-19 death toll is equivalent to number of people killed in all of world’s wars since 1982
Are vaccines already helping contain COVID-19? Early signs say yes, but mutations will be challenging
Infection rates have declined in countries that have inoculated a large share of the population
Scientific innovation in 2021: Lessons from COVID-19
One of the bigger learnings of 2020 was that it takes time, planning, trust and bringing together of resources as well as knowledge to manage a …
Results from Novavax vaccine trials in the UK and South Africa differ: why, and does it matter?
The efficacy of the vaccine was 89 per cent in United Kingdom and 60 per cent in South Africa
Most of us support mandatory vaccines for schoolkids, but is it good policy?
Overwhelming scientific evidence proves the safety and efficacy of vaccination to control, yet Canada is not meeting its childhood-vaccination targets
India may conduct trial or bridging study on Russian COVID-19 vaccine: Govt
Would India also go EUA way on vaccine? Official says, too early to say anything
Five-in-one vaccine now available for free in Delhi healthcare facilities
Activists concerned about deaths caused by pentavalent vaccine
China shifts focus to variant-specific vaccines as it faces an imminent Omicron wave
XBB subvariant has potential to wreak more havoc in China as large number of people immunologically susceptible
India to be 'leading manufacturer' of Russia’s 'doubtful' trial vaccine
Experts caution Indian government against hastened response; Russia researchers claim their vaccine is the best
How ‘good’ does a COVID-19 vaccine need to be? A new study has answers
A vaccine with an efficacy as low as 60% could still stop the pandemic. However, most, if not all of the population, would have to be vaccinated
Polio outbreak in Papua New Guinea after 18 years; experts say it was avoidable
They put the blame on poor vaccination coverage and unsanitary living conditions
Africa’s 1st malaria vaccine: Global alliance Gavi announces $160 million support for rollout
International support will facilitate increased vaccine access to children
Monkeypox outbreak brings focus back on smallpox vaccines. But which countries have stock?
Smallpox vaccination was discontinued after smallpox was eradicated in the 1980s
Why Europe is the epicentre of COVID-19 protests
The reasons for the protests were wide-ranging
As told to Parliament (July 27, 2021): Government to start COVID-19 vaccinations of children from August
All that was discussed in the House through the day
Global measles outbreak: Is this the new pandemic?
187 countries report measles cases
When generics turn into Big Pharma
Top generics firms, some from India, are charged with price-fixing and sleazy deals; Sun Pharma has paid up to settle claims
COVID-19: Activists slam Centre’s affidavit washing hands off compensation for vaccine mortality
There was a huge lack of transparency about vaccine-related complications in the government’s awareness campaigns, activists said
Can nasal vaccines shield against breakthrough infections?
New study argues that nasal vaccines may be necessary to achieve more robust immunity and protection from reinfection by future variants
Clever coronavirus: Spike mutations help Omicron dodge antibodies
Research findings can help developers of vaccines, treatments understand what part of novel coronavirus to target
WHO’s urgent call: World needs new antimicrobial resistance vaccines
Urges equitable and global access to existing vaccines as well